GT: The Podcast

In this special episode of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Ike Ahmed, MD; George Durr, MD; and Ticiana De Francesco, MD, share lessons learned on their use of the MicroShunt since its release. Together, they offer pre-operative, intra- operative, and post-operative suggestions, tips for patient selection, proper positioning, and more based on the retrospective clinical studies conducted, in part, by Dr. Durr and Dr. Ahmed.1,2

1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print.

2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.

In this special edition of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Michelle Lim, MD; Davinder Grover, MD; and James Brandt, MD, analyze their experience with the MicroShunt-a controlled micro-incisional ab-externo glaucoma filtration surgery device. Together, they share their surgical procedures and pearls, how to deal with the complications of post-op blebs, and proper mitomycin dosage based on the recent INN005 clinical trial findings.1  

1. Baker ND, Barnebey HS, Moster MR, et al; INN005 study group. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: 1-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021 :S0161-6420(21 )00384-00385.

In this episode of GT: The Podcast, Lama Al-Aswad, MD, MPH, reads her article, “Equal Pay for Equal Work: Closing Ophthalmology’s Gender Gap in Compensation,” written with Sunidhi Ramesh, BS, and Aakriti Garg Shukla, MD, for the March/April 2021 issue of Glaucoma Today. This article takes a deep dive into the gender gap that still exists in the field of ophthalmology, breaks down the wage statistics, and looks at the multifactorial ways that the disparities in pay can be mitigated.

Deborah Ristvedt, DO, and Mark Gallardo, MD, join Inder Paul Singh, MD, to discuss what constitutes controlled glaucoma. How have their perspectives and management strategies evolved?

In this episode of GT: The Podcast, Lynn W. Sun, MD, PhD, reads her article, "In Advocation of Advocacy," from the March/April 2021 issue of Glaucoma Today. Dr. Sun makes her case for the importance of medical advocacy and describes how her fellow physicians can get involved.

Lynn K. Gordon, MD, PhD, Emeritus Professor of Ophthalmology and Senior Associate Dean of the David Geffen School of Medicine at UCLA, Los Angeles, discusses the concept of allyship. She offers insight into what it means to be an ally and how effective allyship can help us achieve greater equity and inclusion, as featured in her article in the March/April 2021 issue of Glaucoma Today.

Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in the January/February 2021 issue of Glaucoma Today.

Welcome to episode 1 of Dose & Delivery, a new podcast series from GT: the Podcast. Nathan Radcliffe, MD, and Steven R. Sarkisian Jr, MD, join Inder Paul Singh, MD, to discuss evolutions in their approaches to glaucoma management. Learn about their experiences with a bimatoprost intracameral implant (Durysta, Allergan).

Richie Kahn, MPH, a health policy professional, clinical researcher, and patient advisor, offers his perspective as a patient who has had to navigate visits to the glaucoma clinic over the past year. Also, Andrew Iwach, MD, discusses a video resource for patients that demonstrates the measures providers are taking to safely deliver glaucoma care during the pandemic, as featured in the January/February 2021 issue of Glaucoma Today.

Edmund Tsui, MD, an assistant professor of ophthalmology at the Stein Eye Institute at the David Geffen School of Medicine at UCLA, offers a primer on Twitter for ophthalmologists looking to get started with social media, as featured in the January/February 2021 issue of Glaucoma Today.